Assembly Biosciences (ASMB) Stock Price, Quote, News & History | Benzinga

SPY765.54+0.38%QQQ742.80+0.41%BTC/USD83,553.89−0.00%DIA510.23+0.33%GLD381.00+0.04%TLT77.77−0.01%

Assembly Biosciences Inc (ASMB) Stock Price, Quote, News & History

ASMBNASDAQ

Trade with Public

Trade with Public

$23.49

0.010.04%

Last update: Sep 30, 4:00 PM

$23.49

0.010.04%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$23.65

Close

$23.49

Volume / Avg.

221.15K / 268.60K

Day Range

$23.23 - $23.87

52 Wk Range

21.80 - 39.71

Market Cap

$478.27M

P/E Ratio

18.92

Dividend Yield

-

Exchange

NASDAQ

RSI

28

Short Interest

13.7%

Days to Cover

6.26

Recent Assembly Biosciences Inc News

Crude Oil Edges Higher; US Consumer Sentiment Falls In May

US stocks rose, Dow gained over 400 points. S&P 500 and NASDAQ also up. Health care shares jumped, while communication services fell. University of Michigan's consumer sentiment index hit record low. Oil up, gold and silver down. European and Asian markets closed higher.

Avi Kapoor

Zoom Upbeat Q1 Results, Joins Lionsgate Studios, Ross Stores And Other Big Stocks Moving Higher On Friday

Zoom Communications Inc shares rise after strong financial results and increased buyback authorization. Other big gainers include IMRX, INFQ, ASMB, IMAX, RGTI, HLIT, DELL, EL, GSIT, ELVR, and HPQ.

Avi Kapoor

Scholastic Posts Upbeat Q3 Earnings, Joins Firefly Aerospace, Arm Holdings And Other Big Stocks Moving Higher On Friday

Scholastic Corp (NASDAQ: SCHL) rose 10.7% on Friday after reporting better-than-expected earnings and announcing a $200 million buyback. Other big gainers include Planet Labs PBC (NYSE: PL), Satellogic Inc (NASDAQ: SATL), and Blacksky Technology Inc (NYSE: BKSY).

Avi Kapoor

Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes

Gilead licensed Assembly Bio's long-acting HSV drugs after Phase 1b data showed antiviral activity and weekly oral dosing potential.

Vandana Singh

4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week technical strength and strong price action.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-38.48M

Investing Cash Flow (TTM)

-234.51M

Financing Cash Flow (TTM)

281.27M

Free Cash Flow (TTM)

-38.57M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

8.28M

Analyst Trends and Forecast

1

Apr

2

May

1

Jun

1

Aug

2

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$159.75M

PE Ratio (TTM)

18.92

PE Ratio (FWD)

476.19

PEG Ratio (TTM)

-

PS Ratio (TTM)

5.13

PB Ratio (TTM)

1.56

Earnings Yield % (TTM)

5.28%

Earnings Yield % (FWD)

0.21%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$15.01

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$32.29M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-